Jared Mirsky - Speaker at USA CBD Expo 2019

Pelin Thorogood

San Diego, CA USA

Company: Wholistic Research and Education Foundation

Position: President & Co-Founder

Speaking Topic: The Therapeutic Promise of CBD: What We Know

Skills: Research, Education, Advocacy

Pelin’s Biography

Pelin Thorogood is a tech executive turned social entrepreneur who has made a career out of being at the forefront of emerging business trends and technologies. The potential for CBD-rich therapeutics to deliver significant health benefits has led Pelin to co-found Wholistic Research and Education Foundation (Wholistic) in 2017, where she serves as President. Wholistic is a federally-approved public charity, dedicated to exploring if, how, and why CBD may benefit certain health conditions and leveraging this evidence-based data for education and advocacy.  With an unwavering focus on data and analytics throughout her career, previously Pelin was CEO of Anametrix, an award-winning multi-channel analytics platform (acquired by Ensighten 2014) and CMO of WebSideStory, the pioneer in web analytics (IPO 2004, acquired by Omniture/Adobe 2008). Pelin holds a B.S. in Operations Research, Masters in Engineering and MBA degrees, all from Cornell University, where she also serves as Industry Scholar for the Cornell Institute of Healthy Futures

About Wholistic Research and Education Foundation

Medical use of cannabis is currently legal in 33 states and the District of Columbia, with a steady increase in both patients and medical practitioners. While CBD is not yet FDA approved for any conditions (with the notable exception of the recent approval of Epidiolex™ as anti-seizure medication), many NIH and international studies have shown promising results for a variety of conditions. These include cancer, acute and chronic pain, PTSD, Alzheimer’s disease, psychosis, insomnia and Parkinson’s disease. Furthermore, according to the World Health Organization Expert Committee on Drug Dependence (ECDD), CBD does not have psychoactive properties and has no potential for abuse and no potential to produce dependence.

However, key gaps remain in the clinical and observational research for conclusive evidence on the therapeutic benefits of CBD, understanding of the specific mechanisms involved, and how the outcomes may vary based on generic differences.

Follow On Social Media:

Website Linkedin